Related Experiment Video
Updated: Mar 19, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
miR-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion and migration by targeting JAK2
1Department of Oncology, the Yantaishan Hospital, Yantai, Shandong Province, China.
Abstract:
Aberrant expression of microRNA is associated with the development and progression of cancers. MicroRNA-204 (miR-204) down-regulation has been previously demonstrated in non-small-cell lung carcinoma (NSCLC); however, the underlying mechanism by which miR-204 suppresses tumorigenesis in NSCLC remains elusive. In this study, miR-204 expression was found to be down-regulated, and that of Janus kinase 2 (JAK2) was found to be up-regulated in four NSCLC cell lines (A549, H1299, H1650, and H358) compared to the normal lung cell line. The overexpression of miR-204 suppressed the invasive and migratory capacities of H1299 cells. A luciferase assay confirmed that the binding of miR-124 to the -untranslated region of JAK2 inhibited the expression of JAK2 proteins in H1299 cells. JAK-2 overexpression effectively reversed miR-204-repressed NSCLC metastasis. Taken together, our findings revealed that miR-204 functions as a tumor suppressor in NSCLC by targeting JAK2, and that miR-204 may therefore serve as a biomarker for the diagnosis and treatment of NSCLC.
Insights
MicroRNA-204 (miR-204) suppresses non-small-cell lung carcinoma (NSCLC) progression by targeting Janus kinase 2 (JAK2). This discovery highlights miR-204 as a potential biomarker for NSCLC diagnosis and treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Aberrant microRNA expression is linked to cancer development and progression.
- MicroRNA-204 (miR-204) is known to be downregulated in non-small-cell lung carcinoma (NSCLC).
- The precise mechanism by which miR-204 inhibits tumorigenesis in NSCLC is not fully understood.
Purpose of the Study:
- To elucidate the mechanism of miR-204 tumor suppression in NSCLC.
- To investigate the relationship between miR-204 and Janus kinase 2 (JAK2) in NSCLC.
- To evaluate the potential of miR-204 as a diagnostic and therapeutic biomarker for NSCLC.
Main Methods:
- Comparative analysis of miR-204 and JAK2 expression in NSCLC cell lines versus normal lung cells.
- Overexpression of miR-204 in H1299 NSCLC cells to assess effects on invasion and migration.
- Luciferase assay to confirm direct targeting of JAK2 by miR-204.
- JAK2 overexpression studies to validate its role in reversing miR-204-mediated effects.
Main Results:
- miR-204 expression was downregulated, while JAK2 expression was upregulated in NSCLC cell lines.
- Overexpression of miR-204 significantly reduced the invasive and migratory capacities of H1299 cells.
- Luciferase assays confirmed that miR-204 directly targets the 3'-untranslated region of JAK2, inhibiting its expression.
- JAK2 overexpression counteracted the anti-metastatic effects of miR-204 in NSCLC cells.
Conclusions:
- miR-204 functions as a tumor suppressor in NSCLC by directly targeting and downregulating JAK2.
- The miR-204/JAK2 pathway plays a critical role in regulating NSCLC metastasis.
- miR-204 holds promise as a valuable biomarker for NSCLC diagnosis and a potential target for novel therapeutic strategies.
Related Concept Videos
Cancer Cell Migration through Invadopodia
MicroRNAs
MicroRNAs
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Cell Migration

